Cedar Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-37
| Closed | -$21.4K | – | 207 |
|
|
2025
Q4 | $21.4K | Hold |
37
| – | – | 0.01% | 145 |
|
|
2025
Q3 | $17.9K | Hold |
37
| – | – | 0.01% | 156 |
|
|
2025
Q2 | $15K | Hold |
37
| – | – | 0.01% | 148 |
|
|
2025
Q1 | $18.4K | Hold |
37
| – | – | 0.01% | 138 |
|
|
2024
Q4 | $19.2K | Sell |
37
-12
| -24% | -$6.6K | 0.01% | 130 |
|
|
2024
Q3 | $30.3K | Sell |
49
-80
| -62% | -$47.4K | 0.01% | 174 |
|
|
2024
Q2 | $71.3K | Sell |
129
-5
| -4% | -$2.86K | 0.02% | 148 |
|
|
2024
Q1 | $77.9K | Buy |
134
+17
| +15% | +$9.54K | 0.03% | 143 |
|
|
2023
Q4 | $62.1K | Hold |
117
| – | – | 0.02% | 146 |
|
|
2023
Q3 | $59.2K | Buy |
117
+35
| +43% | +$18.7K | 0.02% | 148 |
|
|
2023
Q2 | $42.8K | Buy |
82
+80
| +4,000% | +$43.2K | 0.02% | 164 |
|
|
2023
Q1 | $1.15K | Sell |
2
-1
| -33% | -$564 | ﹤0.01% | 287 |
|
|
2022
Q4 | $1.65K | Hold |
3
| – | – | ﹤0.01% | 275 |
|
|
2022
Q3 | $2K | Sell |
3
-26
| -90% | -$14.6K | ﹤0.01% | 308 |
|
|
2022
Q2 | $16K | Hold |
29
| – | – | 0.01% | 242 |
|
|
2022
Q1 | $17K | Hold |
29
| – | – | 0.01% | 263 |
|
|
2021
Q4 | $19K | Buy |
29
+4
| +16% | +$2.5K | 0.01% | 253 |
|
|
2021
Q3 | $14K | Hold |
25
| – | – | 0.01% | 221 |
|
|
2021
Q2 | $13K | Buy |
+25
| New | +$11.8K | 0.01% | 225 |
|
|
2019
Q3 | – | Sell |
-1,068
| Closed | -$314K | – | 172 |
|
|
2019
Q2 | $314K | Hold |
1,068
| – | – | 0.2% | 43 |
|
|
2019
Q1 | $292K | Sell |
1,068
-223
| -17% | -$55.5K | 0.18% | 44 |
|
|
2018
Q4 | $289K | Sell |
1,291
-10
| -0.8% | -$2.35K | 0.21% | 41 |
|
|
2018
Q3 | $318K | Sell |
1,301
-77
| -6% | -$17.7K | 0.17% | 44 |
|
|
2018
Q2 | $285K | Sell |
1,378
-1
| -0.1% | -$212 | 0.16% | 36 |
|
|
2018
Q1 | $285K | Buy |
1,379
+5
| +0.4% | +$1.05K | 0.18% | 37 |
|
|
2017
Q4 | $261K | Sell |
1,374
-2
| -0.1% | -$383 | 0.16% | 37 |
|
|
2017
Q3 | $260K | Sell |
1,376
-35
| -2% | -$6.34K | 0.15% | 39 |
|
|
2017
Q2 | $246K | Sell |
1,411
-62
| -4% | -$10.4K | 0.16% | 40 |
|
|
2017
Q1 | $226K | Buy |
1,473
+53
| +4% | +$8.1K | 0.14% | 46 |
|
|
2016
Q4 | $200K | Hold |
1,420
| – | – | 0.14% | 50 |
|
|
2016
Q3 | $226K | Buy |
1,420
+43
| +3% | +$6.63K | 0.16% | 30 |
|
|
2016
Q2 | $203K | Buy |
1,377
+342
| +33% | +$50.5K | 0.13% | 45 |
|
|
2016
Q1 | $147K | Buy |
+1,035
| New | +$139K | 0.1% | 36 |
|
Other funds holding TMO
Cedar Wealth Management's TMO Position: Q1 2026 in Review
Cedar Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 37 shares — an estimated $21.4K sold.
Cedar Wealth Management first reported a position in TMO in Q1 2016 and held it in 33 quarters. The position peaked at $318K in Q3 2018. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Cedar Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- Cedar Wealth Management sold 37 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.4K.
- Cedar Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 33 quarters.
- Cedar Wealth Management's Thermo Fisher Scientific position peaked at $318K in Q3 2018.
- 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Cedar Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.